NASDAQ: BRTX
Biorestorative Therapies Inc Stock Ownership - Who owns Biorestorative Therapies?

Insider buying vs selling

Have Biorestorative Therapies Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Dale Broadrick10% Owner2024-10-281,112$1.58
$1.76kSell

1 of 1

BRTX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BRTX insiders and whales buy or sell their stock.

BRTX Shareholders

What type of owners hold Biorestorative Therapies Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Westbury Bermuda Ltd876.11%65,750,000$106.52MInsider
Trust Westbury253.83%19,049,578$30.86MInsider
Antonio Joel San166.56%12,500,000$20.25MInsider
Janet Montgomery24.71%1,854,428$3.00MInsider
Dale Broadrick23.90%1,793,808$2.91MInsider
John M. Desmarais6.57%493,398$799.30kInsider
Joseph B. Swiader2.55%191,267$309.85kInsider
Lance Alstodt2.29%171,872$278.43kInsider
Francisco Silva2.24%167,895$271.99kInsider
Paul Jude Tonna1.65%123,850$200.64kInsider

1 of 3

BRTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BRTX0.27%99.73%Net Selling
ABP2.59%53.89%Net BuyingNet Buying
BCDA0.13%99.87%Net BuyingNet Buying
BTAI0.19%99.81%Net Selling
BIVI2.01%97.99%

Biorestorative Therapies Stock Ownership FAQ

Who owns Biorestorative Therapies?

Biorestorative Therapies (NASDAQ: BRTX) is owned by 3.76% institutional shareholders, 1,364.06% Biorestorative Therapies insiders, and 0.00% retail investors. Westbury Bermuda Ltd is the largest individual Biorestorative Therapies shareholder, owning 65.75M shares representing 876.11% of the company. Westbury Bermuda Ltd's Biorestorative Therapies shares are currently valued at $105.20M.

If you're new to stock investing, here's how to buy Biorestorative Therapies stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.